IRIS
DEGIACOMI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.552
AS - Asia 1.136
EU - Europa 948
SA - Sud America 193
AF - Africa 69
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.902
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.490
CN - Cina 349
SG - Singapore 283
IE - Irlanda 245
VN - Vietnam 164
HK - Hong Kong 159
RU - Federazione Russa 151
BR - Brasile 149
DE - Germania 111
IT - Italia 108
FI - Finlandia 79
FR - Francia 69
GB - Regno Unito 52
ZA - Sudafrica 48
IN - India 45
CA - Canada 33
UA - Ucraina 29
JP - Giappone 23
MX - Messico 22
SE - Svezia 19
AT - Austria 16
BD - Bangladesh 15
PL - Polonia 14
TR - Turchia 14
IQ - Iraq 13
BE - Belgio 11
VE - Venezuela 11
CO - Colombia 10
ES - Italia 10
NL - Olanda 8
PK - Pakistan 8
EC - Ecuador 7
UZ - Uzbekistan 7
AR - Argentina 6
CZ - Repubblica Ceca 6
ID - Indonesia 6
PH - Filippine 6
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
IL - Israele 4
KR - Corea 4
TW - Taiwan 4
AO - Angola 3
AU - Australia 3
CL - Cile 3
LT - Lituania 3
LV - Lettonia 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
TN - Tunisia 3
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
LB - Libano 2
NP - Nepal 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CH - Svizzera 1
CM - Camerun 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MG - Madagascar 1
NA - Namibia 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 3.902
Salva come PNG Salva come JPEG
Città #
Dublin 245
Chandler 185
San Jose 184
Ashburn 168
Singapore 153
Hong Kong 148
Dallas 111
Beijing 90
Los Angeles 60
Ho Chi Minh City 56
Boardman 55
Helsinki 52
Munich 49
Pavia 48
Johannesburg 43
Hanoi 42
Lauterbourg 41
New York 41
Jacksonville 36
Nanjing 36
Lawrence 30
Medford 30
Princeton 30
Shanghai 30
Moscow 28
Santa Clara 21
Tokyo 21
Redondo Beach 20
Wilmington 17
Orem 16
São Paulo 15
The Dalles 14
Turku 14
Buffalo 13
Vienna 13
Nanchang 12
Warsaw 12
Frankfurt am Main 10
London 10
Montreal 10
Nuremberg 10
Changsha 9
Chennai 9
Haiphong 9
Mexico City 9
Ottawa 9
Shenyang 9
Ann Arbor 8
Chicago 8
Hangzhou 8
Phoenix 8
Piscataway 8
Stockholm 8
Brussels 7
Jiaxing 7
Paris 7
San Francisco 7
San Genesio ed Uniti 7
Biên Hòa 6
Cinisello Balsamo 6
Columbus 6
Council Bluffs 6
Falkenstein 6
Hebei 6
Hyderabad 6
Milan 6
New Delhi 6
Olomouc 6
Tashkent 6
Toronto 6
Atlanta 5
Boston 5
Charlotte 5
Chongqing 5
Da Nang 5
Houston 5
Istanbul 5
Manchester 5
Mumbai 5
Tianjin 5
Washington 5
Birmingham 4
Bến Tre 4
Caracas 4
Erbil 4
Medellín 4
Naples 4
Rio de Janeiro 4
Seattle 4
Woodbridge 4
Achel 3
Amsterdam 3
Brasília 3
Brooklyn 3
Curitiba 3
Dearborn 3
Denver 3
Draper 3
Fiorano Modenese 3
Fortaleza 3
Totale 2.549
Salva come PNG Salva come JPEG
Nome #
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 159
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 156
Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals are Uniformly Susceptible to Benzothiazinones 140
A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors 140
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 129
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 127
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 123
A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis 116
A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis 112
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG. 112
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 108
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 107
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 106
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis 104
Pyridine-2-thiol 1-oxide derivatives and their use for treatment of mammalian infections caused by Mycobacterium or fungi 103
First triclosan-based macrocyclic inhibitors of InhA enzyme 100
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 99
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 98
Nitric oxide-releasing compounds for the treatment of lung infections 91
GarA is an essential regulator of metabolism in mycobacterium tuberculosis 91
Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound. 84
Age-related changes in PD-1 expression coincide with increased cytotoxic potential in Vδ2 T cells during infancy 84
The antimalarial mefloquine shows activity against mycobacterium abscessus, inhibiting mycolic acid metabolism 81
Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosis. 80
Promoter mutagenesis for fine-tuning expression of essential genes in Mycobacterium tuberculosis 80
Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options 75
Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression 75
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 74
Distinct Effects of Moxifloxacin and Bedaquiline on Growing and 'Non-Culturable' Mycobacterium abscessus 73
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. 72
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 71
Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium 70
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 70
Concomitant assessment of PD-1 and CD56 expression identifies subsets of resting cord blood Vδ2 T cells with disparate cytotoxic potential 69
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 69
Exploring the plasticity of the InhA substrate-binding site using new diaryl ether inhibitors 63
Micrococcin P1 – A bactericidal thiopeptide active against Mycobacterium tuberculosis 61
The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo 58
Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis 57
The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis 57
P146 New weapons are necessary to fight Mycobacterium abscessus 56
New Drugs and Novel Cellular Targets against Tuberculosis 47
PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis 47
Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes—Hydrazones with Antileishmanial and Antibacterial Activities 46
Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3 45
Whole cell screen based identification of spiropiperidines with potent antitubercular properties 41
Uncovering insights into the biology of Mycobacterium tuberculosis using genetic tools 14
Totale 4.040
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.081
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 7 9 2
2021/2022141 5 1 1 0 2 2 5 14 8 5 14 84
2022/2023598 47 54 7 33 42 59 1 34 293 7 10 11
2023/2024300 50 52 8 16 18 54 12 28 5 15 26 16
2024/2025827 22 47 31 7 31 73 48 40 207 40 104 177
2025/20261.839 127 125 208 228 258 91 369 97 221 115 0 0
Totale 4.040